Medical Liability: S.B. 6 (2015)

|

Links the noneconomic damages limit to the Consumer Price Index,


Links the noneconomic damages limit to the Consumer Price Index, requires appellate courts to review the standards applied to admitting expert testimony de novo, and excludes amounts written off a medical bill by a thirty party from the definition of a “collateral source.”

Latest News

View all news

SCOTUS Should Affirm Federal Law Supremacy With FDA Authority Case

The U.S. Supreme Court has a chance to rein in state court rulings that impose liability on pharmaceutical companies that go beyond, and even contradict, the federal regulatory process of the FDA, according to Tiger Joyce, president of the American Tort Reform Association. He explains why it is imperative the high court review a case involving Janssen Pharmaceuticals.